Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Research article

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1in the gastric epithelium

Authors: Tomoe Nomura, Tomomitsu Tahara, Hisakazu Shiroeda, Takahiro Minato, Yasuhiro Matsue, Ranji Hayashi, Kazuhiro Matsunaga, Toshimi Otsuka, Masakatsu Nakamura, Nobuyuki Toshikuni, Tomoyuki Shibata, Tomiyasu Arisawa

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Aberrant methylation patterns in CpG island are known to be influential in gene silencing. Histamine plays important physiological roles in the upper gastrointestinal tract and acts via the H2 receptor. We report an investigation into the effect of HRH2 promoter polymorphism (rs2607474 G > A) on the methylation of DAPK and CDH1.

Methods

Non cancerous gastric mucosa samples were obtained from 115 subjects with gastric cancer (GC) and 412 non-cancer subjects (non-GC). Methylation status of genes was determined by MSP. The genotyping of rs2607474 was performed by PCR-SSCP.

Results

Methylation of DAPK and CDH1 was observed in 296 and 246 subjects, respectively. The frequency of CDH1 methylation in the subjects with GC was significantly lower in cancer lesion than in non cancerous mucosa, whereas that of DAPK methylation was not different. The allelic distribution of rs2607474 was 401GG, 119GA and 7AA. The GG homozygote was associated with a significantly increased risk for methylation of both DAPK and CDH1 (p < 0.0001 and p = 0.0009, respectively). In the non-GC subjects or more than 60 years of age, GG homozygote was more closely associated with both DAPK and CDH1 methylation. However, this genotype did not show an increased risk for the development of methylation of both genes in patients with GC. In H. pylori negative subjects, GG homozygote showed an increased risk for the methylation of both DAPK and CDH1 (p = 0.0074 and p = 0.0016, respectively), whereas this genotype was associated with an increased risk for the development of DAPK methylation in H. pylori positive subjects (p = 0.0018). In addition, in subjects older than 60 years of age, atrophy and metaplasia scores were significantly higher in the GG homozygote (p = 0.011 and p = 0.039, respectively) and a significant correlation was observed between age and atrophy or metaplasia.

Conclusions

Our results suggest that rs2607474 GG homozygote confers a significantly increased risk for age- and inflammation-related DAPK and CDH1 methylation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed
2.
go back to reference Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006, 24: 2137-2150. 10.1200/JCO.2005.05.2308.CrossRefPubMed Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006, 24: 2137-2150. 10.1200/JCO.2005.05.2308.CrossRefPubMed
3.
go back to reference Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res. 2001, 61: 3225-3229.PubMed Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res. 2001, 61: 3225-3229.PubMed
4.
go back to reference Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T: Increased number of CpG island hypermethylation in tumor suppressor genes of Non-neoplastic gastric mucosa correlates with higher risk of gastric cancer. Digestion. 2010, 82: 27-36. 10.1159/000252766.CrossRefPubMed Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T: Increased number of CpG island hypermethylation in tumor suppressor genes of Non-neoplastic gastric mucosa correlates with higher risk of gastric cancer. Digestion. 2010, 82: 27-36. 10.1159/000252766.CrossRefPubMed
5.
go back to reference Kass SU, Pruss D, Wolffe AP: How does DNA methylation repress transcription?. Trends Genet. 1997, 13: 444-449. 10.1016/S0168-9525(97)01268-7.CrossRefPubMed Kass SU, Pruss D, Wolffe AP: How does DNA methylation repress transcription?. Trends Genet. 1997, 13: 444-449. 10.1016/S0168-9525(97)01268-7.CrossRefPubMed
6.
go back to reference Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994, 4: 536-540.CrossRef Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994, 4: 536-540.CrossRef
7.
go back to reference Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998, 23: 5489-5494. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998, 23: 5489-5494.
8.
go back to reference Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001, 61: 3573-3577.PubMed Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001, 61: 3573-3577.PubMed
9.
go back to reference Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM, Meltzer SJ: Hypermethylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res. 2002, 62: 1148-1151.PubMed Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM, Meltzer SJ: Hypermethylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res. 2002, 62: 1148-1151.PubMed
10.
go back to reference Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J: p16 Inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett’s esophagus. Gastroenterology. 2002, 122: 1113-1121. 10.1053/gast.2002.32370.CrossRefPubMed Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J: p16 Inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett’s esophagus. Gastroenterology. 2002, 122: 1113-1121. 10.1053/gast.2002.32370.CrossRefPubMed
11.
go back to reference Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T: High levels of aberrant DNA methylation in helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006, 12: 989-995. 10.1158/1078-0432.CCR-05-2096.CrossRefPubMed Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T: High levels of aberrant DNA methylation in helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006, 12: 989-995. 10.1158/1078-0432.CCR-05-2096.CrossRefPubMed
12.
go back to reference Tahara T, Arisawa T, Sibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H, Nakamura M, Hasegawa S, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H: Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion. 2007, 75: 54-61. 10.1159/000101775.CrossRefPubMed Tahara T, Arisawa T, Sibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H, Nakamura M, Hasegawa S, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H: Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion. 2007, 75: 54-61. 10.1159/000101775.CrossRefPubMed
13.
go back to reference Kang GH, Lee S, Lim JS, Jung HY: Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 2003, 83: 635-641.CrossRefPubMed Kang GH, Lee S, Lim JS, Jung HY: Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 2003, 83: 635-641.CrossRefPubMed
14.
go back to reference Tahara T, Arisawa T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Hirata I: Increased number of methylated CpG islands correlates with helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur J Gastroenterol Hepatol. 2009, 21: 613-619. 10.1097/MEG.0b013e32830e28b2.CrossRefPubMed Tahara T, Arisawa T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Hirata I: Increased number of methylated CpG islands correlates with helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur J Gastroenterol Hepatol. 2009, 21: 613-619. 10.1097/MEG.0b013e32830e28b2.CrossRefPubMed
15.
go back to reference Rangachari PK: Histamine: mercurial messenger in the gut. Am J Physiol. 1992, 262: G1-G13.PubMed Rangachari PK: Histamine: mercurial messenger in the gut. Am J Physiol. 1992, 262: G1-G13.PubMed
16.
go back to reference Black J, Duncan W, Durant D: Definition and antagonism of histamine H2-receptors. Nature. 1972, 236: 385-390. 10.1038/236385a0.CrossRefPubMed Black J, Duncan W, Durant D: Definition and antagonism of histamine H2-receptors. Nature. 1972, 236: 385-390. 10.1038/236385a0.CrossRefPubMed
17.
go back to reference Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH: Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut. 1987, 28: 1120-1127. 10.1136/gut.28.9.1120.CrossRefPubMedPubMedCentral Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH: Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut. 1987, 28: 1120-1127. 10.1136/gut.28.9.1120.CrossRefPubMedPubMedCentral
18.
go back to reference Bodger K, Crabtree JE: Helicobacter pylori and gastric inflammation. Br Med Bull. 1998, 54: 139-150. 10.1093/oxfordjournals.bmb.a011664.CrossRefPubMed Bodger K, Crabtree JE: Helicobacter pylori and gastric inflammation. Br Med Bull. 1998, 54: 139-150. 10.1093/oxfordjournals.bmb.a011664.CrossRefPubMed
19.
go back to reference Mancama D, Arranz MJ, Munro J, Osborne S, Makoff A, Collier D, Kerwin R: Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci Lett. 2002, 333: 207-211. 10.1016/S0304-3940(02)00178-7.CrossRefPubMed Mancama D, Arranz MJ, Munro J, Osborne S, Makoff A, Collier D, Kerwin R: Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci Lett. 2002, 333: 207-211. 10.1016/S0304-3940(02)00178-7.CrossRefPubMed
20.
go back to reference Garcia-Martin E, Ayuso P, Luengo A, Martinez C, Agundez JAG: Genetic variability of histamine receptors in patients with Parkinson’s disease. BMC Med Genet. 2008, 9: 15-CrossRefPubMedPubMedCentral Garcia-Martin E, Ayuso P, Luengo A, Martinez C, Agundez JAG: Genetic variability of histamine receptors in patients with Parkinson’s disease. BMC Med Genet. 2008, 9: 15-CrossRefPubMedPubMedCentral
21.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996, 20: 1161-1181.CrossRefPubMed Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996, 20: 1161-1181.CrossRefPubMed
22.
go back to reference Katzenellenbogen RA, Baylin SB, Herman JG: Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood. 1999, 93: 4347-4353.PubMed Katzenellenbogen RA, Baylin SB, Herman JG: Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood. 1999, 93: 4347-4353.PubMed
23.
go back to reference Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996, 93: 9821-9826. 10.1073/pnas.93.18.9821.CrossRefPubMedPubMedCentral Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996, 93: 9821-9826. 10.1073/pnas.93.18.9821.CrossRefPubMedPubMedCentral
24.
go back to reference Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H: The relationship between helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med. 2007, 19: 143-148.PubMed Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H: The relationship between helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med. 2007, 19: 143-148.PubMed
25.
go back to reference Arisawa T, Tahara T, Ozaki K, Matsue Y, Minato T, Yamada H, Nomura T, Hayashi R, Matsunaga K, Fukumura A, Nakamura M, Toshikuni N, Shiroeda H, Shibata T: Association between common genetic variant of HRH2 and gastric cancer risk in Japanese population. Int J Oncol. in press Arisawa T, Tahara T, Ozaki K, Matsue Y, Minato T, Yamada H, Nomura T, Hayashi R, Matsunaga K, Fukumura A, Nakamura M, Toshikuni N, Shiroeda H, Shibata T: Association between common genetic variant of HRH2 and gastric cancer risk in Japanese population. Int J Oncol. in press
26.
go back to reference Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H: A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects. Dis Dig Sci. 2007, 52: 1691-1697. 10.1007/s10620-006-9648-5.CrossRef Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H: A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects. Dis Dig Sci. 2007, 52: 1691-1697. 10.1007/s10620-006-9648-5.CrossRef
27.
go back to reference Hu XC, Loo WT, Chow LW: E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life Sci. 2002, 71: 1397-1404. 10.1016/S0024-3205(02)01843-X.CrossRefPubMed Hu XC, Loo WT, Chow LW: E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life Sci. 2002, 71: 1397-1404. 10.1016/S0024-3205(02)01843-X.CrossRefPubMed
28.
go back to reference Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M, Scartozzi M, Cascinu S: Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol. 2004, 15: 489-492. 10.1093/annonc/mdh108.CrossRefPubMed Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M, Scartozzi M, Cascinu S: Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol. 2004, 15: 489-492. 10.1093/annonc/mdh108.CrossRefPubMed
29.
go back to reference Bai T, Tanaka T, Yukawa K, Maeda M, Umesaki N: Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells. Oncol Rep. 2004, 11: 661-665.PubMed Bai T, Tanaka T, Yukawa K, Maeda M, Umesaki N: Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells. Oncol Rep. 2004, 11: 661-665.PubMed
30.
go back to reference Kim WS, Son HJ, Park JO, Song SY, Park C: Promoter methylation and down-regulation of DAPK is associated with gastric atrophy. Int J Mol Med. 2003, 12: 827-830.PubMed Kim WS, Son HJ, Park JO, Song SY, Park C: Promoter methylation and down-regulation of DAPK is associated with gastric atrophy. Int J Mol Med. 2003, 12: 827-830.PubMed
31.
go back to reference Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H: CpG island hypermethylation of tumor-suppressor genes in H. Pylori - infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter. 2008, 13: 35-41.CrossRefPubMed Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H: CpG island hypermethylation of tumor-suppressor genes in H. Pylori - infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter. 2008, 13: 35-41.CrossRefPubMed
32.
go back to reference Tahara T, Arisawa T: Potential usefulness of DNA methylation as a risk marker for digestive cancer. Expert Rev Mol Diagn. 2012, 12: 489-497. 10.1586/erm.12.38.CrossRefPubMed Tahara T, Arisawa T: Potential usefulness of DNA methylation as a risk marker for digestive cancer. Expert Rev Mol Diagn. 2012, 12: 489-497. 10.1586/erm.12.38.CrossRefPubMed
33.
go back to reference Ito C, Morisset S, Krebs MO, Olié JP, Lôo H, Poirier MF, Lannfelt L, Schwartz JC, Arrang JM: Histamine H2 receptor gene variants: lack of association with schizophrenia. Mol Psychiatry. 2000, 5: 159-164. 10.1038/sj.mp.4000664.CrossRefPubMed Ito C, Morisset S, Krebs MO, Olié JP, Lôo H, Poirier MF, Lannfelt L, Schwartz JC, Arrang JM: Histamine H2 receptor gene variants: lack of association with schizophrenia. Mol Psychiatry. 2000, 5: 159-164. 10.1038/sj.mp.4000664.CrossRefPubMed
34.
go back to reference Correa P: Human gastric carcinogenesis: a multistep and multifactorial process. First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992, 52: 6735-6740.PubMed Correa P: Human gastric carcinogenesis: a multistep and multifactorial process. First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992, 52: 6735-6740.PubMed
35.
go back to reference Kuipers EJ, Uyterlinde AM, Peña AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG: Increase of helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995, 90: 1401-1406.PubMed Kuipers EJ, Uyterlinde AM, Peña AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG: Increase of helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995, 90: 1401-1406.PubMed
36.
go back to reference Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG: Atrophic gastritis and helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996, 334: 1018-1022. 10.1056/NEJM199604183341603.CrossRefPubMed Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG: Atrophic gastritis and helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996, 334: 1018-1022. 10.1056/NEJM199604183341603.CrossRefPubMed
37.
go back to reference Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P: Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux esophagitis after treatment with lansoprazole. Gut. 1997, 41: 740-747. 10.1136/gut.41.6.740.CrossRefPubMedPubMedCentral Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P: Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux esophagitis after treatment with lansoprazole. Gut. 1997, 41: 740-747. 10.1136/gut.41.6.740.CrossRefPubMedPubMedCentral
38.
go back to reference Poynter D, Selway SA: Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent Fundic stomach. Mutat Res. 1991, 248: 303-319. 10.1016/0027-5107(91)90064-U.CrossRefPubMed Poynter D, Selway SA: Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent Fundic stomach. Mutat Res. 1991, 248: 303-319. 10.1016/0027-5107(91)90064-U.CrossRefPubMed
39.
go back to reference Brenna E, Swarts HG, Klaassen CH, de Pont JJ, Waldum HL: Evaluation of the trophic effect of longterm treatment with the histamine H2 receptor antagonist loxtidine on rat oxyntic mucosa by differential counting of dispersed cells. Gut. 1994, 35: 1547-1550. 10.1136/gut.35.11.1547.CrossRefPubMedPubMedCentral Brenna E, Swarts HG, Klaassen CH, de Pont JJ, Waldum HL: Evaluation of the trophic effect of longterm treatment with the histamine H2 receptor antagonist loxtidine on rat oxyntic mucosa by differential counting of dispersed cells. Gut. 1994, 35: 1547-1550. 10.1136/gut.35.11.1547.CrossRefPubMedPubMedCentral
40.
go back to reference Hunyady B, Zolyomi A, Czimmer J, Mózsik G, Kozicz T, Buzás E, Tanaka S, Ichikawa A, Nagy A, Palkovits M, Falus A: Expanded parietal cell pool in transgenic mice unable to synthesize histamine. Scand J Gastroenterol. 2003, 38: 133-140.CrossRefPubMed Hunyady B, Zolyomi A, Czimmer J, Mózsik G, Kozicz T, Buzás E, Tanaka S, Ichikawa A, Nagy A, Palkovits M, Falus A: Expanded parietal cell pool in transgenic mice unable to synthesize histamine. Scand J Gastroenterol. 2003, 38: 133-140.CrossRefPubMed
Metadata
Title
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1in the gastric epithelium
Authors
Tomoe Nomura
Tomomitsu Tahara
Hisakazu Shiroeda
Takahiro Minato
Yasuhiro Matsue
Ranji Hayashi
Kazuhiro Matsunaga
Toshimi Otsuka
Masakatsu Nakamura
Nobuyuki Toshikuni
Tomoyuki Shibata
Tomiyasu Arisawa
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-1

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.